Clinical trial
Multi-omics Characterization and Model Construction of Colchicine Anti-inflammatory Therapy Efficacy in Acute Coronary Syndromes Patients
NCT07064109 is registered in ClinicalTrials.gov with Shanghai Tongji Hospital, Tongji University School of Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Multi-omics Characterization and Model Construction of Colchicine Anti-inflammatory Therapy Efficacy in Acute Coronary Syndromes Patients
- Lead sponsor
- Shanghai Tongji Hospital, Tongji University School of Medicine
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- July 1, 2025
- Completion date
- July 1, 2027
- Enrollment
- 380 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
acs - acute coronary syndrome